CareDx Showcases Leading Transplant Data at ASN 2020
Eleven clinical abstracts on AlloSure have been selected for presentation during the poster and publication sessions of the conference, indicating that general nephrologists have a growing interest in surveillance tools for transplant patient management.
Vasil Peev, Rush University: Clinical Utility of Kidney Transplant Surveillance with AlloSure
Sanjiv Anand, Intermountain Medical Center: Baseline Characteristics and Relative Change Value of AlloSure
Tarek Alhamad, Washington University School of Medicine: AlloSure as a Predictor of Clinical Outcomes
Nicole Ali, NYU Langone Health: COVID-19 and Renal Transplantation: The NYU Experience
Adit Mahale, Metrolina Nephrology Associates: AlloSure Experience in the Community
“I am looking forward to presenting real-world AlloSure surveillance data across 1000 patients from multiple centers. It is really positive to see confirmation of the validation data in a cohort of real-world transplant patients, as well as the associations with meaningful clinical outcomes,” said Dr.
“ASN is a tremendous opportunity for the nephrology community to share their experiences and to talk about best practices in kidney care for patients. This conference allows us to update the general nephrologists on the work that
Chief Marketing Officer
Source: CareDx, Inc.